ArticleOncoTargets and therapy2019

Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma.

Lucy Swift et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.